Low Anticoagulant Heparin (LAH) derivatives
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,371
NCT00710242
Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2007
Completion: May 31, 2009
NCT03001193
Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest
Start: Dec 31, 2016
Completion: May 31, 2019
NCT03978247
Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy
Phase: N/A
Start: Jun 21, 2019
Completion: Oct 31, 2020
NCT04000438
Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix
Completion: Mar 30, 2023
Loading map...